MX2017014197A - Complejos no covalentes basados en albumina y metodos de uso de los mismos. - Google Patents

Complejos no covalentes basados en albumina y metodos de uso de los mismos.

Info

Publication number
MX2017014197A
MX2017014197A MX2017014197A MX2017014197A MX2017014197A MX 2017014197 A MX2017014197 A MX 2017014197A MX 2017014197 A MX2017014197 A MX 2017014197A MX 2017014197 A MX2017014197 A MX 2017014197A MX 2017014197 A MX2017014197 A MX 2017014197A
Authority
MX
Mexico
Prior art keywords
albumin
methods
same
covalent complexes
complexes based
Prior art date
Application number
MX2017014197A
Other languages
English (en)
Other versions
MX388753B (es
Inventor
Verma Ravi
Yu Changjun
Original Assignee
Spectral Platforms Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectral Platforms Inc filed Critical Spectral Platforms Inc
Publication of MX2017014197A publication Critical patent/MX2017014197A/es
Publication of MX388753B publication Critical patent/MX388753B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)

Abstract

Se proporcionan un complejo no covalente de una molécula de albúmina y un ligando hidrofóbico, composiciones que contienen los mismos, y métodos de uso de los mismos. El presente complejo puede encontrar uso en suministrar el ligando hidrofóbico a microorganismos que tienen superficies exteriores que se enlazan a la albúmina, tal como una pared celular.
MX2017014197A 2015-05-08 2016-05-06 Complejos no covalentes basados en albúmina y métodos de uso de los mismos. MX388753B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562158670P 2015-05-08 2015-05-08
US201662294931P 2016-02-12 2016-02-12
PCT/US2016/031273 WO2016182929A1 (en) 2015-05-08 2016-05-06 Albumin-based non-covalent complexes and methods of use thereof

Publications (2)

Publication Number Publication Date
MX2017014197A true MX2017014197A (es) 2018-08-15
MX388753B MX388753B (es) 2025-03-20

Family

ID=57221697

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014197A MX388753B (es) 2015-05-08 2016-05-06 Complejos no covalentes basados en albúmina y métodos de uso de los mismos.

Country Status (5)

Country Link
US (5) US10071141B2 (es)
EP (2) EP3978618A1 (es)
JP (2) JP6983660B2 (es)
MX (1) MX388753B (es)
WO (1) WO2016182929A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6983660B2 (ja) 2015-05-08 2021-12-17 スペクトラル プラットフォームス インコーポレイテッド アルブミンに基づく非共有結合性複合体およびその使用方法
WO2018175346A1 (en) * 2017-03-20 2018-09-27 Spectral Platforms, Inc. Spectroscopic methods to detect and characterize microorganisms
CN109009828B (zh) * 2018-06-22 2020-09-22 遵义医学院 神经元取材操作台支架装置
WO2020081460A1 (en) * 2018-10-17 2020-04-23 Sunstate Biosciences, LLC Single protein-encapsulated pharmaceutics for enhancing therapeutic effects
CN113577075A (zh) * 2021-08-20 2021-11-02 滕兆刚 一种纳米药物及其制备方法、应用

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576414A (en) 1976-05-25 1980-10-08 Ucb Sa Anti-bacterially-active penicillins
US4226846A (en) * 1977-04-01 1980-10-07 New England Nuclear Corporation Albumin microaggregates for radioactive scanning of reticuloendothelial systems
US4187285A (en) 1977-12-16 1980-02-05 E. R. Squibb & Sons, Inc. Microaggregated albumin
WO1988006457A1 (fr) 1987-03-04 1988-09-07 Nippon Hypox Laboratories Incorporated Composition medicinale contenant de l'albumine en tant que support et procede de preparation
JP2654445B2 (ja) * 1987-03-04 1997-09-17 株式会社富士薬品 天然アルブミンを担体とした医薬組成物及びその製法
JPS63297664A (ja) 1987-05-28 1988-12-05 三井建設株式会社 コンクリ−ト打設装置
JPS63297464A (ja) * 1987-05-29 1988-12-05 Hitoshi Shibata 脂溶性天然色素一蛋白複合体
US5134126A (en) * 1987-11-09 1992-07-28 Bayer Ag Antimycotic compositions of nikkomycin compounds and azole antimycotics
US5082771A (en) 1989-06-27 1992-01-21 Eastman Kodak Company Detecting cells using tellurapyrylium dihydroxides
JPH03272440A (ja) 1990-02-16 1991-12-04 Hitachi Ltd ラマン分光光度計
US5301125A (en) 1990-09-26 1994-04-05 Exxon Research & Engineering Company Spectroscopic determination of amount of one constituent of a fluid mixture in another constituent or in the fluid mixture itself, following separation of the mixture into its constituents
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5364766A (en) 1993-05-14 1994-11-15 Minnesota Mining And Manufacturing Company Culture medium for rapid count of coliform bacteria
US5439801A (en) 1994-02-14 1995-08-08 Chek-Med Systems, Inc. Test composition for the rapid detection of helicobacter pylori in gastric biopsy tissue
US5464755A (en) 1994-04-29 1995-11-07 Biolog, Inc. Microbiological medium and method of assay
US6040906A (en) 1996-07-11 2000-03-21 Harhay; Gregory P. Resonance raman spectroscopy for identifying and quantitating biomatter, organic, and inorganic analytes
DE69729898D1 (de) 1996-09-16 2004-08-19 R & F Lab Inc Methode und medium zur isolierung und identifizierung von escherichia coli 0157:h7
JP3636849B2 (ja) 1996-11-14 2005-04-06 キッコーマン株式会社 微生物の薬剤感受性試験法、同試験用キット、微生物の最少発育阻止濃度測定法並びに同測定用キット
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
US6659613B2 (en) 2000-03-27 2003-12-09 Board Of Regents, The University Of Texas System Methods and systems for measuring local scattering and aberration properties of optical media
US7829348B2 (en) 2000-09-22 2010-11-09 Iowa State University Research Foundation, Inc. Raman-active reagents and the use thereof
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
FR2826018B1 (fr) 2001-06-18 2005-01-07 Pasteur Institut Tunis Gene associe a la virulence du parasite leishmania
US6750006B2 (en) 2002-01-22 2004-06-15 Microbiosystems, Limited Partnership Method for detecting the presence of microbes and determining their physiological status
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
US20050009788A1 (en) 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
EP2392562B1 (en) * 2002-07-29 2018-03-07 Cardax Pharma, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
JP3895317B2 (ja) 2002-10-21 2007-03-22 株式会社日本触媒 分光光度計用試料保持体および分光光度計
AU2003299561A1 (en) 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
CN103405405A (zh) * 2002-12-09 2013-11-27 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
US8450079B2 (en) 2003-10-31 2013-05-28 Immunetics, Inc. Method for detecting bacteria
US7271896B2 (en) * 2003-12-29 2007-09-18 Intel Corporation Detection of biomolecules using porous biosensors and raman spectroscopy
EP1738212B1 (en) 2004-04-16 2010-08-25 Auburn University Microscope illumination device and adapter thereof
US20070141714A1 (en) * 2005-12-19 2007-06-21 Intel Corporation Method to detect small molecules binding to proteins using surface enhanced Raman scattering (SERS)
WO2007083817A1 (en) 2006-01-18 2007-07-26 Canon Kabushiki Kaisha Target substance-detecting element
US8078427B2 (en) 2006-08-21 2011-12-13 Agilent Technologies, Inc. Calibration curve fit method and apparatus
US8852504B2 (en) 2006-10-11 2014-10-07 The Board Of Trustees Of The University Of Illinois Apparatus and method for detecting and identifying microorganisms
AP2746A (en) * 2006-11-29 2013-09-30 Microsens Medtech Ltd Capture of mycobacteria like micro-organisms
TW200837349A (en) 2007-03-07 2008-09-16 Nat Univ Tsing Hua Biochip and manufacturing method thereof
US20110045470A1 (en) * 2007-08-01 2011-02-24 Hitachi Chemical Co., Ltd. Pathogen detection in large-volume particulate samples
US8252522B2 (en) 2007-08-14 2012-08-28 The Regents Of The University Of California Species detection methods and systems
JP5434199B2 (ja) 2009-03-31 2014-03-05 東洋紡株式会社 抗酸菌遺伝子の増幅方法
KR101066197B1 (ko) * 2009-04-06 2011-09-20 한국생명공학연구원 코엔자임 ｑ10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
CN102770071B (zh) 2009-12-15 2015-03-25 爱默蕾大学 用于在诊断或治疗程序中提供实时解剖学指导的系统和方法
FR2955664B1 (fr) 2010-01-22 2012-02-10 Centre Nat Rech Scient Methode pour la detection d'un signal optique non lineaire resonant et dispositif pour la mise en oeuvre de ladite methode
CN103733050A (zh) * 2011-08-22 2014-04-16 光谱平台有限公司 代谢活性的快速检测
US9417234B2 (en) 2012-01-31 2016-08-16 The University Of Toledo Methods and devices for detection and measurement of analytes
US9513294B2 (en) 2012-12-26 2016-12-06 National University Of Singapore Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing
US9778282B2 (en) 2013-03-15 2017-10-03 Anasys Instruments Method and apparatus for infrared scattering scanning near-field optical microscopy with high speed point spectroscopy
EP3922965A3 (en) 2013-08-07 2022-03-30 Wayne State University Hand-held micro-raman based detection instrument and method of detection
WO2016060301A1 (ko) 2014-10-16 2016-04-21 주식회사 퀀타매트릭스 고정화제를 이용한 단일 세포 추적을 위한 신규한 생리 활성 검사용 구조물
JP6983660B2 (ja) 2015-05-08 2021-12-17 スペクトラル プラットフォームス インコーポレイテッド アルブミンに基づく非共有結合性複合体およびその使用方法
US10801964B2 (en) 2015-07-30 2020-10-13 The Research Foundation For The State University Of New York Spectroscopic methods for body fluid age determination
US20170191020A1 (en) 2015-12-30 2017-07-06 Palo Alto Research Center Incorporated Thermochromic sensing devices, systems, and methods
WO2018175346A1 (en) 2017-03-20 2018-09-27 Spectral Platforms, Inc. Spectroscopic methods to detect and characterize microorganisms
EP3580348A4 (en) 2017-03-29 2021-04-07 Specific Technologies, LLC SENSITIVITY AND RESISTANCE OF MICROORGANISMS

Also Published As

Publication number Publication date
JP2022033810A (ja) 2022-03-02
US20160324933A1 (en) 2016-11-10
US12357679B2 (en) 2025-07-15
EP3294900B1 (en) 2021-09-22
EP3294900A4 (en) 2018-09-19
US10071141B2 (en) 2018-09-11
US10342855B2 (en) 2019-07-09
US20210290734A1 (en) 2021-09-23
US20190030135A1 (en) 2019-01-31
US20240075107A1 (en) 2024-03-07
JP6983660B2 (ja) 2021-12-17
JP2018524265A (ja) 2018-08-30
US10940183B2 (en) 2021-03-09
US20200121763A1 (en) 2020-04-23
JP7501918B2 (ja) 2024-06-18
WO2016182929A1 (en) 2016-11-17
MX388753B (es) 2025-03-20
EP3294900A1 (en) 2018-03-21
EP3978618A1 (en) 2022-04-06

Similar Documents

Publication Publication Date Title
MX381718B (es) Agentes biologicos y su uso en plantas.
BR112015023752A2 (pt) complexos multiespecificos monovalentes e multivalentes e seus usos
MX2017013613A (es) Neoepitodos de cancer.
CL2016002310A1 (es) Nuevos compuestos bicíclicos.
MX2016011619A (es) Anticuerpos anti-egfrviii y usos de los mismos.
WO2015002724A3 (en) SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
CL2016002735A1 (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
IL252970A0 (en) Compositions and methods for high efficiency in vivo genome editing
PH12021552158A1 (en) Antibodies to icos
CL2016000807A1 (es) Amino heteroarilo benzamidas como inhibidores de quinasa.
UA115773C2 (uk) Пірольні сполуки, спосіб їх одержання та фармацевтична композиція, що їх містить (варіанти)
EA201691194A1 (ru) Стимуляторы ргц
MX389749B (es) Sistemas y métodos para el uso simultáneo del espectro dentro del espectro usado activamente.
CL2014001865A1 (es) Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer.
MX377340B (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
CL2016001604A1 (es) “compuestos derivados de pirazolo[1,5-a]piridina, inhibidores de quinasas axl y c-met; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer”. pct
CL2015002304A1 (es) Formas del metil {4,6-diamino-2- [1- (2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato
EP3415518A4 (en) MACROCYCLUS AND COMPOSITION THEREOF
MX2017014197A (es) Complejos no covalentes basados en albumina y metodos de uso de los mismos.
MX2016004802A (es) Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso.
MX2017004076A (es) Moleculas biespecificas que comprenden un brazo orientado a la envoltura vih-1.
EP3166616A4 (en) Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment
Mathai Fractional integral operators involving many matrix variables
WO2016108927A3 (en) Nitrification inhibitor compositions and methods for preparing the same
BR112016027043A2 (pt) Combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer